Advertisement
Screener

Amgen Inc. (AMGN) Graph

AMGN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $10.05B; Cost of revenue $2.81B; Selling, general and administrative $1.75B; Income tax $393.00M.
  • 2026-03-31: Revenue $8.62B; Cost of revenue $2.74B; Selling, general and administrative $1.60B; Income tax $265.00M.
  • 2025-12-31: Revenue $9.87B*; Cost of revenue $2.98B*; Selling, general and administrative $1.95B*; Income tax $181.00M*.
  • 2025-09-30: Revenue $9.56B; Cost of revenue $3.08B; Selling, general and administrative $1.72B; Income tax $705.00M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

AMGN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product AndService Other$517.00MProduct$9.54BAranesp$352.00MBLINCYTO$472.00MEVENITY$714.00MEnbrel$580.00MIMDELLTRAIMDYLLTRA$288.00MKRYSTEXXA$400.00MKyprolis$314.00MNplate$430.00MOtezla$491.00MOther Products$1.70BProlia$759.00MRepathaevolocumab$953.00MTEPEZZA$576.00MTEZSPIRE$486.00MUPLIZNA$335.00MVectibix$338.00MXgeva$352.00MRevenue$10.05BCost of revenue$2.81BOperating income$3.51BSelling, general& administrative$1.74BPre-tax income$2.77BIncome tax$393.00MNet income$2.38B

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-30$10.05B$2.81B$1.75B$393.00M$2.38B
2026-03-31$8.62B$2.74B$1.60B$265.00M$1.82B
2025-12-31$9.87B*$2.98B*$1.95B*$181.00M*$1.33B*
2025-09-30$9.56B$3.08B$1.72B$705.00M$3.22B
2025-06-30$9.18B$3.01B$1.69B$136.00M$1.43B
2025-03-31$8.15B$2.97B$1.69B$243.00M$1.73B
2024-09-30$8.50B$3.31B$1.63B$271.00M$2.83B
2024-06-30$8.39B$3.24B$1.78B$48.00M$746.00M
2024-03-31$7.45B$3.20B$1.81B$45.00M-$113.00M
2023-09-30$6.90B$1.81B$1.35B$217.00M$1.73B
2023-06-30$6.99B$1.81B$1.29B$235.00M$1.38B
2023-03-31$6.11B$1.72B$1.26B$601.00M$2.84B
2022-09-30$6.65B$1.59B$1.29B$249.00M$2.14B
2022-06-30$6.59B$1.51B$1.33B$214.00M$1.32B
2022-03-31$6.24B$1.56B$1.23B$199.00M$1.48B
2021-09-30$6.71B$1.61B$1.30B$271.00M$1.88B
2021-06-30$6.53B$1.64B$1.38B$94.00M$464.00M
2021-03-31$5.90B$1.49B$1.25B$211.00M$1.65B
2020-12-31(m)(m)(m)(m)$1.61B
2020-09-30$6.42B$1.56B$1.35B$185.00M$2.02B
2020-06-30$6.21B$1.49B$1.29B$227.00M$1.80B
2020-03-31$6.16B$1.51B$1.32B$195.00M$1.82B
2019-12-31(m)(m)(m)(m)$1.70B
2019-09-30$5.74B$1.04B$1.22B$309.00M$1.97B
2019-06-30$5.87B$1.01B$1.26B$385.00M$2.18B
2019-03-31$5.56B$1.05B$1.15B$322.00M$1.99B
2018-12-31(m)(m)(m)(m)$1.93B
2018-09-30$5.90B$1.04B$1.29B$235.00M$1.86B
2018-06-30$6.06B$1.02B$1.35B$351.00M$2.30B
2018-03-31$5.55B$944.00M$1.13B$308.00M$2.31B
2017-12-31(m)(m)(m)(m)-$4.26B
2017-09-30$5.77B$990.00M$1.17B$360.00M$2.02B
2017-06-30$5.81B$1.02B$1.21B$391.00M$2.15B
2017-03-31$5.46B(m)$1.06B$389.00M$2.07B
2016-12-31(m)(m)(m)(m)$1.94B
2016-09-30$5.81B(m)$1.24B$401.00M$2.02B
2016-06-30$5.69B(m)$1.29B$334.00M$1.87B
2016-03-31$5.53B(m)$1.20B$358.00M$1.90B
2015-12-31(m)(m)(m)(m)$1.80B
2015-09-30$5.72B(m)$1.24B$329.00M$1.86B
2015-06-30$5.37B(m)$1.16B$344.00M$1.65B
2015-03-31$5.03B(m)$1.03B$253.00M$1.62B
2014-12-31(m)(m)(m)(m)$1.29B
2014-09-30$5.03B(m)$1.21B$93.00M$1.24B
2014-06-30$5.18B(m)$1.14B$211.00M$1.55B
2014-03-31$4.52B(m)$1.02B$131.00M$1.07B
2013-12-31(m)(m)(m)(m)$1.02B
2013-09-30$4.75B(m)$1.25B$135.00M$1.37B
2013-06-30$4.68B(m)$1.26B$147.00M$1.26B
2013-03-31$4.24B(m)$1.16B-$91.00M$1.43B
2012-12-31(m)(m)(m)(m)$788.00M
2012-09-30$4.32B(m)$1.13B$156.00M$1.11B
2012-06-30$4.48B(m)$1.23B$191.00M$1.27B
2012-03-31$4.05B(m)$1.08B$182.00M$1.18B
2011-12-31(m)(m)(m)(m)$934.00M
2011-09-30$3.94B(m)$1.13B$0.00$454.00M
2011-06-30$3.96B(m)$1.13B$169.00M$1.17B
2011-03-31$3.71B(m)$1.02B$181.00M$1.13B
2010-12-31(m)(m)(m)(m)$1.02B
2010-09-30$3.82B(m)$957.00M$198.00M$1.24B
2010-06-30$3.80B(m)$986.00M$262.00M$1.20B
2010-03-31$3.59B(m)$884.00M$253.00M$1.17B
2009-12-31(m)(m)(m)(m)$931.00M
2009-09-30$3.81B(m)$932.00M$154.00M$1.39B
2009-06-30$3.71B(m)$910.00M$88.00M$1.27B
2009-03-31$3.31B(m)$798.00M$213.00M$1.02B
2008-09-30$3.88B(m)$900.00M$291.00M$1.12B
2008-06-30$3.76B(m)$904.00M$224.00M$906.00M

Revenue and expense 6 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2026-06-30$18.67B$5.55B$3.35B$658.00M$4.19B
2025-06-30$17.33B$5.98B$3.38B$379.00M$3.16B
2024-06-30$15.84B$6.44B$3.59B$93.00M$633.00M
2023-06-30$13.09B$3.53B$2.55B$836.00M$4.22B
2022-06-30$12.83B$3.07B$2.56B$413.00M$2.79B
2021-06-30$12.43B$3.13B$2.64B$305.00M$2.11B
2020-06-30$12.37B$3.00B$2.61B$422.00M$3.63B
2019-06-30$11.43B$2.07B$2.41B$707.00M$4.17B
2018-06-30$11.61B$1.97B$2.48B$659.00M$4.61B
2017-06-30$11.27B$2.02B$2.27B$780.00M$4.22B
2016-06-30$11.21B(m)$2.50B$692.00M$3.77B
2015-06-30$10.40B(m)$2.19B$597.00M$3.28B
2014-06-30$9.70B(m)$2.16B$342.00M$2.62B
2013-06-30$8.92B(m)$2.41B$56.00M$2.69B
2012-06-30$8.53B(m)$2.31B$373.00M$2.45B
2011-06-30$7.67B(m)$2.15B$350.00M$2.29B
2010-06-30$7.40B(m)$1.87B$515.00M$2.37B
2009-06-30$7.02B(m)$1.71B$301.00M$2.29B
2008-06-30$7.38B(m)$1.78B$504.00M$2.01B

Revenue and expense 9 month

Period endRevenueCost of revenueSelling, general and administrativeIncome taxNet income
2025-09-30$26.89B$9.06B$5.10B$1.08B$6.38B
2024-09-30$24.34B$9.75B$5.22B$364.00M$3.46B
2023-09-30$19.99B$5.34B$3.90B$1.05B$5.95B
2022-09-30$19.48B$4.66B$3.84B$662.00M$4.94B
2021-09-30$19.13B$4.74B$3.94B$576.00M$3.99B
2020-09-30$18.79B$4.56B$3.96B$607.00M$5.65B
2019-09-30$17.16B$3.10B$3.64B$1.02B$6.14B
2018-09-30$17.52B$3.00B$3.77B$894.00M$6.47B
2017-09-30$17.05B$3.01B$3.44B$1.14B$6.24B
2016-09-30$17.03B(m)$3.74B$1.09B$5.79B
2015-09-30$16.13B(m)$3.43B$926.00M$5.14B
2014-09-30$14.73B(m)$3.37B$435.00M$3.86B
2013-09-30$13.66B(m)$3.66B$191.00M$4.06B
2012-09-30$12.84B(m)$3.44B$529.00M$3.56B
2011-09-30$11.61B(m)$3.28B$350.00M$2.75B
2010-09-30$11.21B(m)$2.83B$713.00M$3.60B
2009-09-30$10.83B(m)$2.64B$455.00M$3.67B
2008-09-30$11.25B(m)$2.68B$795.00M$3.13B

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueSelling, general and administrativeIncome taxNet income
2025-12-31$36.75B(m)$12.04B$7.05B$1.26B$7.71B
2024-12-31$33.42B(m)$12.86B$7.10B$519.00M$4.09B
2023-12-31$28.19B(m)$8.45B$6.18B$1.14B$6.72B
2022-12-31$26.32B$26.32B$6.41B$5.41B$794.00M$6.55B
2021-12-31$25.98B$25.98B$6.45B$5.37B$808.00M$5.89B
2020-12-31$25.42B$25.42B$6.16B$5.73B$869.00M$7.26B
2019-12-31$23.36B$23.36B$4.36B$5.15B$1.30B$7.84B
2018-12-31$23.75B$23.75B$4.10B$5.33B$1.15B$8.39B
2017-12-31$22.85B$22.85B$4.07B$4.87B$7.62B$1.98B
2016-12-31$22.99B(m)$4.16B$5.06B$1.44B$7.72B
2015-12-31$21.66B(m)(m)$4.85B$1.04B$6.94B
2014-12-31$20.06B(m)(m)$4.70B$427.00M$5.16B
2013-12-31$18.68B(m)(m)$5.18B$184.00M$5.08B
2012-12-31$17.27B(m)(m)$4.81B$664.00M$4.34B
2011-12-31$15.58B(m)(m)$4.50B$467.00M$3.68B
2010-12-31$15.05B(m)(m)$3.98B$690.00M$4.63B
2009-12-31$14.64B(m)(m)$3.82B$599.00M$4.61B
2008-12-31$15.00B(m)(m)$3.79B$963.00M$4.05B
2007-12-31$14.77B(m)(m)$3.36B$715.00M$3.08B

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31